The trademark application IMZAXTA was filed by Kite Pharma, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 6, 2018, and it was registered by office on November 13, 2018 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 1, 2019. Appointment and Replacement of representative of the trademark registration was recorded on November 22, 2019.